Your session is about to expire
← Back to Search
Kinesiology Tape
Kinesio Tape for Delayed Onset Muscle Soreness
N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 to 30 years old
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this instrument will be administered at baseline
Awards & highlights
Study Summary
This trial is testing whether Kinesio tape can help with muscle soreness after a workout.
Who is the study for?
This trial is for healthy individuals aged 18 to 30 who haven't done upper body strengthening exercises recently. It's not for those with recent injuries/surgeries, chronic conditions requiring medication, allergies to tape/adhesives, or certain heart/blood pressure issues.Check my eligibility
What is being tested?
The study tests if Kinesio tape can reduce muscle soreness in the biceps after intense exercise. Participants will have their arm muscles taped and then assessed for any changes in soreness levels.See study design
What are the potential side effects?
Potential side effects include skin irritation or allergic reactions to the Kinesio tape. Since it's a non-invasive treatment, serious side effects are unlikely.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 30 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ this instrument will be administered at baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this instrument will be administered at baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Range of Motion, Articular
Change in Maximal Strength of non-dominant bicep.
Change in average pain in previous 24 hours
+4 moreSecondary outcome measures
Change in Self-reported function of the affected arm
Reinjuries
Pain catastrophizing
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Kinesiotape (KT)Experimental Treatment1 Intervention
Tape will be applied to the biceps muscle of the nondominant arm from approximately the shoulder to the elbow for up to 72 hours. For the KT group taping will be applied with a lymphatic application method according to the guidelines recommended by Kenzo Kase. This type of application is known to improve blood and lymphatic circulation which enhances the removal of metabolic products. The tape will be applied with a tension of 10-20%.
Group II: No TapeActive Control1 Intervention
This group will not receive any intervention.
Group III: Placebo KinesiotapePlacebo Group1 Intervention
Tape will be applied to the biceps muscle of the nondominant arm from approximately the shoulder to the elbow for up to 72 hours. The placebo KT group will have 0% tension.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Kinesiotape
2021
N/A
~660
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,240 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not had any injuries or surgeries to my neck or arms in the last 6 months.I take over-the-counter pain meds like Tylenol or Advil on test days.I am on medication for a long-term health issue.I have open or healing wounds on my arm where tape would be applied.I am between 18 and 30 years old.My doctor has diagnosed me with a heart condition or high blood pressure.You have been doing any exercises or activities to make your arm muscles stronger in the past month.You have been doing exercises to make your arms stronger and more flexible twice a month for the past 6 months.I take nutritional supplements or anti-inflammatory medication daily.If your skin becomes irritated by the tape.I have lost balance or consciousness due to dizziness in the last year.If you answer "yes" to any of the seven questions on the first page of the 2019 Physical Activity Readiness Questionnaire, it means you may not be ready for exercise without a medical exam.I experience chest pain, whether I'm resting, doing daily tasks, or exercising.I have had bone, joint, or muscle problems in the past year that could worsen with more physical activity.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo Kinesiotape
- Group 2: Kinesiotape (KT)
- Group 3: No Tape
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are accepted into this experiment?
"Indeed, the information available on clinicaltrials.gov illustrates that this medical trial is still in need of participants. First posted on January 30th 2020 and last updated on January 11th 2022, the study hopes to enrol 36 individuals at one site."
Answered by AI
To whom does this research study extend the opportunity to participate?
"This clinical trial aims to find 36 individuals with muscle tissue between 18 and 30 years of age. In order to be eligible, applicants must meet the following requirement: being within the age range of 18-30."
Answered by AI
Does the trial involve geriatric patients?
"The age range for eligibility in this trial is restricted to those aged 18-30, as noted by the prerequisites."
Answered by AI
Is there still a window of opportunity to join this clinical experiment?
"Affirmative, the information available on clinicaltrials.gov highlights that this research is actively searching for suitable participants. It was initially posted in January 2020 and most recently modified in early January 2022; 36 patients are needed at a single medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger